American Medical Systems, Inc. v. Biolitec, Inc.

666 F. Supp. 2d 216, 2009 U.S. Dist. LEXIS 101525, 2009 WL 3490620
District Court, D. Massachusetts·Decided October 28, 2009·No. Civil Action 08-30061-MAP·Published·Cited by 4 cases

Opinion

MEMORANDUM AND ORDER REGARDING CONSTRUCTION OF PATENT CLAIMS

PONSOR, District Judge.

I. INTRODUCTION

Plaintiffs American Medical Systems, Inc. (“AMS”) and Laserscope, Inc. brought suit against Defendant Biolitec, Inc. (“Biolitec”) and related companies on March 21, 2008, alleging infringement of U.S. Patent No. 5,428,699 (issued June 27, 1995) (“the '699 Patent”). (Dkt. No. 1.) The parties have submitted briefs on the construction of the patent claims, and the task before the court now is to “determin[e] the meaning and scope of the patent claims asserted to be infringed.” Markman v. Westview Instruments, Inc., 52 F.3d 967, 976 (Fed.Cir.1995).

II. BACKGROUND

Generally, the '699 Patent describes a side-firing laser probe that delivers laser energy to prostate tissue to vaporize or ablate it and to reduce the size of the organ. This procedure is useful in the treatment of Benign Prostatic Hyperplasia, a condition in which an enlarged prostate compromises functioning of the bladder and urethra. Vaporization, or ablation, of some of the prostate tissue allows reduction of the prostate to a more comfortable size.

The side-firing laser system utilizes a laser probe that consists, principally, of a fiber-optic core surrounded by a cladding or sheath, which may or may not be surrounded by other layers of material. Laser light travels along the fiber core before reflecting off a surface at an angle such that 90% of the laser energy or more passes through a particular area on the transmitting surface and ultimately hits the prostate tissue. The cladding has a lower index of refraction than the fiber core to ensure that the laser light is internally reflected back into the fiber and does not “leak” before it is reflected onto the prostate tissue. Plaintiffs contend that Defendants’ device infringes the '699 Patent.

A typical claim of Plaintiffs’ patent describes:

An apparatus for communicating and laterally directing electromagnetic radiation, comprising: a waveguide having a tip for communicating electromagnetic radiation in a propagation direction to the tip of the waveguide; a transmitting surface on the tip of the waveguide; a reflecting surface on the tip of the waveguide for internally reflecting electromagnetic radiation communicated by the waveguide in a direction lateral to the propagation direction toward a particular area on the transmitting surface; and wherein the particular area and the reflecting surface are disposed so that greater than about 90% of the electromagnetic radiation reflected by the reflecting surface is incident on the particular area at below a critical angle for transmission through the transmitting surface in the lateral direction.

The '699 Patent, col. 14, lines 48-64.

Other independent claims cite variations on this method, or particular ways of accomplishing the desired results. The dependent claims add details such as the shape of the tip or parameters of the waveguide.

III. CLAIM CONSTRUCTION

To analyze Plaintiffs’ claims, the court must determine, preliminarily, “the meaning and scope of the patent claims asserted to be infringed.” Markman, 52 F.3d at *219 976. In this case, Plaintiffs assert infringement of Claims 1-2, 4-5, 7-9, 16, 21-23, 25-26, 30, and 33. Of these, Claims 1, 5, 7, and 25 are independent claims. The rest are dependent.

The court’s interpretation of the patent claims must be based on the meaning they would have to “a person of ordinary skill in the art at the time of the invention.” Innova/Pure Water, Inc. v. Safari Water Filtration Sys., Inc., 381 F.3d 1111, 1116 (Fed.Cir.2004). When construing patent claims, “the court should look first to the intrinsic evidence of record, i.e., the patent itself, including the claims, the specification and, if in evidence, the prosecution history.” Vitronics Corp. v. Conceptronic, Inc., 90 F.3d 1576, 1582 (Fed.Cir.1996).

The parties have stipulated to the constructions, which will not be recited at length by the court, of the following ten claim terms:

(1) “propagation direction/propagation directions” (Independent Claims 1, 7; Dependent Claims 5, 9);
(2) “first propagation direction” (Independent Claim 25);
(3) “second propagation direction” (Independent Claim 25);
(4) “lateral”;
(5) “critical angle”;
(6) “a particular area on the transmitting surface”;
(7) “comprising”;
(8) “waveguide”;
(9) “segment”/“portion”; and
(10) “core”.

The parties have been unable to agree on the interpretations of certain other words and phrases in the patent. Set forth below is the court’s construction of the disputed terms appearing in particular patent claims. 1

A. “Transmitting Surface (Independent Claims 1, 7, and 25)

The court finds “transmitting surface” to mean “surface through which electromagnetic radiation is transmitted in the lateral direction.”

The primary dispute between the parties over this term relates to the location of the transmitting surface. Defendants urge a construction that locates the “transmitting surface” on the outer surface of a round core cladding on the waveguide. They point to figures included in the patent (the '699 Patent Figs. 1-4 and 9) that show a transmitting surface located on the outside of the cladding but beneath any glass cap or transparent adhesive or other materials that lie on the outside of the cladding.

Defendants’ limiting construction must be rejected because it would exclude an embodiment of the patent. A definition that excludes an embodiment of the patent is unlikely to be correct or “would require highly persuasive evidentiary support.” Vitronics, 90 F.3d at 1583. The '699 Patent describes an embodiment of the patent in which a “transparent tube” is attached to the tip of the probe with adhesive. In Figure 12, the “transmitting surface” is located on the external surface of the transparent tube and not simply on the outside of the core cladding. Because this embodiment of the '699 Patent describes a transmitting surface located elsewhere than on the core cladding, Defendants’ proposed definition is too restrictive. 2

*220 B.

Free access — add to your briefcase to read the full text and ask questions with AI

American Medical Systems, Inc. v. Biolitec, Inc., 666 F. Supp. 2d 216, 2009 U.S. Dist. LEXIS 101525, 2009 WL 3490620 (D. Mass. 2009).

666 F. Supp. 2d 216 (American Medical Systems, Inc. v. Biolitec, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Dahua Technology USA Inc v. Zhang
D. Massachusetts, 2024
Koninklijke Philips Electronics N.V. v. Zoll Medical Corp.
914 F. Supp. 2d 89 (D. Massachusetts, 2012)
Momenta Pharmaceuticals, Inc. v. Amphastar Pharmaceuticals, Inc.
887 F. Supp. 2d 303 (D. Massachusetts, 2012)
American Medical Systems, Inc. v. Biolitec, Inc.
774 F. Supp. 2d 375 (D. Massachusetts, 2011)